biblio

Export 14 results:
Filters: Author is Sarkar, Dhiman and Keyword is Molecular docking  [Clear All Filters]
2023
S. Singh, Navale, G. R., Agrawal, S., Singh, H. Kisan, Singla, L., Sarkar, D., Sarma, M., Choudhury, A. Roy, and Ghosh, K., “Design and synthesis of piano-stool ruthenium(II) complexes and their studies on the inhibition of amyloid ? (1-42) peptide aggregation”, International Journal of Biological Macromolecules, vol. 239, p. 124197, 2023.
2022
N. C. Desai, Bhatt, K., Jadeja, D. J., Mehta, H. K., Khedkar, V. M., and Sarkar, D., “Conventional and microwave-assisted organic synthesis of novel antimycobacterial agents bearing furan and pyridine hybrids”, Drug Development Research, vol. 83, no. 2, pp. 416-431, 2022.
V. S. Honmore, Natu, A. D., Khedkar, V. M., Arkile, M. A., Sarkar, D., and Rojatkar, S. R., “Two antibacterial spiro compounds from the roots of Artemisia pallens wall: evidence from molecular docking”, Natural Product Research, vol. 36, no. 10, pp. 2465-2472, 2022.
2021
T. S. Chitre, Asgaonkar, K. D., Vikhe, A. B., Patil, S. M., Garud, D. R., Khedkar, V. M., Sarkar, D., Nawale, L. U., and Yeware, A., “In silico studies, synthesis and antitubercular activity of some novel quinoline - azitidinone derivatives”, Current Computer-Aided Drug Design, vol. 17, no. 1, pp. 134-143, 2021.
2019
A. Atmaram Upare, Gadekar, P. K., Sivaramakrishnan, H., Naik, N., Khedkar, V. M., Sarkar, D., Choudhari, A., and S. Roopan, M., “Design, synthesis and biological evaluation of (E)-5-styryl-1,2,4-oxadiazoles as anti-tubercular agents”, Bioorganic Chemistry, vol. 86, pp. 507-512, 2019.
T. S. Chitre, Patil, S. M., Sujalegaonkar, A. G., Asgaonkar, K. D., Khedkar, V. M., Garud, D. R., Jha, P. C., Gaikwad, S. Y., Kulkarni, S., Choudhari, A., and Sarkar, D., “Non nucleoside reverse transcriptase inhibitors, molecular docking studies and antitubercular activity of thiazolidin-4-one derivatives”, Current Computer-Aided Drug Design, vol. 15, no. 5, pp. 433-444, 2019.
V. Shinde, Mahulikar, P., Mhaske, P. C., Chakraborty, S., Choudhari, A., Phalle, S., Choudhari, P., and Sarkar, D., “Synthesis and antimycobacterial evaluation of new 5-(1-benzyl-1H-1,2,3-triazol-4-yl)-4-methyl-2-arylthiazole derivatives”, Medicinal Chemistry Research, vol. 28, no. 6, pp. 805-819, 2019.
2018
S. Gholap, Tambe, M., Nawale, L., Sarkar, D., Sangshetti, J., and Damale, M., “Design, synthesis, and pharmacological evaluation of fluorinated azoles as anti-tubercular agents”, Archiv Der Pharmazie, vol. 351, no. 2, p. e1700294, 2018.
A. B. Danne, “Synthesis and biological evaluation of novel triazole-biscoumarin conjugates as potential antitubercular and anti-oxidant agents”, Research on Chemical Intermediates, vol. 44, no. 10, pp. 1-28, 2018.
Y. Patil, Shingare, R., Choudhari, A., Borkute, R., Sarkar, D., and Madje, B. R., “Synthesis and biological evaluation of some new tricyclic pyrrolo[3,2-e]tetrazolo[1,5-c]pyrimidine derivatives as potential antitubercular agents”, Archiv Der Pharmazie, vol. 351, no. 8, p. e1800040, 2018.
U. D. Nimbalkar, Seijas, J. A., Borkute, R., Damale, M. G., Sangshetti, J. N., Sarkar, D., and Nikalje, A. Pratima G., “Ultrasound assisted synthesis of 4-(Benzyloxy)-N-(3-chloro-2-(substitutedphenyl)-4-oxoazetidin-1-yl) benzamide as challenging anti-tubercular scaffold”, Molecules, vol. 23, no. 8, p. Article No: 1945, 2018.
2016
S. T. Dhumal, Deshmukh, A. R., Bhosle, M. R., Khedkar, V. M., Nawale, L. U., Sarkar, D., and Mane, R. A., “Synthesis and antitubercular activity of new 1,3,4-oxadiazoles bearing pyridyl and thiazolyl scaffolds”, Bioorganic & Medicinal Chemistry Letters, vol. 26, no. 15, pp. 3646-3651, 2016.
P. S. Mahajan, Nikam, M. D., Nawale, L. U., Khedkar, V. M., Sarkar, D., and Gill, C. H., “Synthesis and antitubercular activity of new benzo[b]thiophenes”, ACS Medicinal Chemistry Letters, vol. 7, no. 8, pp. 751-756, 2016.
N. C. Desai, Somani, H., Trivedi, A., Bhatt, K., Nawale, L., Khedkar, V. M., Jha, P. C., and Sarkar, D., “Synthesis, biological evaluation and molecular docking study of some novel indole and pyridine based 1,3,4-oxadiazole derivatives as potential antitubercular agents”, Bioorganic & Medicinal Chemistry Letters, vol. 26, no. 7, pp. 1776-1783, 2016.